Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia.

F Thibaut1, A Van Der Elst, D Campion

  • 1Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen, Rouen, France.

European Psychiatry : the Journal of the Association of European Psychiatrists
|November 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

BMC cancer·2021
Same author

Editor's Choice - Nationwide Analysis of Patients Undergoing Iliac Artery Aneurysm Repair in the Netherlands.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2020
Same author

[A woman with aswelling of the hallux].

Nederlands tijdschrift voor geneeskunde·2016
Same author

Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.

Journal of surgical oncology·2006
Same author

Cognitive patterns in subtypes of schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2002

Apolipoprotein E (ApoE) genotype frequencies did not differ between schizophrenia patients and controls. These findings suggest ApoE does not influence the development of schizophrenia symptoms.

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • The apolipoprotein E (ApoE) genotype is implicated in various neuropsychiatric disorders.
  • Schizophrenia is a complex psychiatric condition with potential genetic underpinnings.
  • Primary negative symptoms are a core feature of schizophrenia, particularly in deficit syndrome.

Purpose of the Study:

  • To investigate the frequency of apolipoprotein E (ApoE) genotypes in schizophrenia patients.
  • To examine the association between ApoE genotype and primary negative symptoms in schizophrenia.
  • To compare ApoE genotype and allele frequencies between schizophrenia subtypes and healthy controls.

Main Methods:

  • Genotyping of apolipoprotein E (ApoE) in 61 non-deficit schizophrenic patients, 45 deficit schizophrenic patients, and 98 control subjects.

Related Experiment Videos

  • Analysis of ApoE genotype and allele frequencies across the three study groups.
  • Statistical comparison of frequencies to determine significant associations.

    • Main Results:

    • No significant differences were observed in apolipoprotein E (ApoE) genotype frequencies among non-deficit schizophrenia, deficit schizophrenia, and control groups.
    • ApoE allele frequencies also showed no significant variation between the patient and control cohorts.
    • The study found no correlation between ApoE genotype and the presence or severity of primary negative symptoms in schizophrenia.

    Conclusions:

    • The apolipoprotein E (ApoE) genotype does not appear to play a significant role in the phenotypic expression of schizophrenia.
    • These findings do not support a genetic link between ApoE and schizophrenia, particularly concerning negative symptoms.
    • Further research may be needed to explore other genetic factors contributing to schizophrenia pathophysiology.